CANADIAN DERIVATIVES CLEARING CORP

8-K · cdcc_8k.htm

8-K
 1
 cdcc_8k.htm
 CURRENT REPORT

 UNITED
STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 FORM 8–K

 CURRENT
REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) : May 31, 2026

 CANADIAN
DERIVATIVES CLEARING CORPORATION

 (Exact
name of registrant as specified in its charter)

Commission File Number: 002-69458

 _____________________________________

 Canada

 N/A

 (State or other jurisdiction
 of incorporation)

 (IRS Employer Identification
 No.)

 1800-1190
av des Canadiens-de-Montréal, P.O. Box 37

Montreal, Quebec, Canada

 H3B
0G7

 (Address of principal executive offices, including zip code)

 514-871-3545

 (Registrant’s telephone number, including area code)

 Not Applicable

 (Former name or former address, if changed since last report)

 Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:

 [ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 [ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 [ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 [ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Item
9.01 Financial Statements and Exhibits.

 (d) Exhibits.

 99.1 List
 of Underlying Interests of Canadian Derivatives Clearing Corporation options listed on the
 Montreal Exchange and offered for sale in the United States pursuant to CDCC’s Registration
 Statement on Form S-20 as of May 31, 2026.

 SIGNATURES

 Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

 By:
 /s/ Karen McMeekin

 Name:
 Karen
 McMeekin

 Title:
 President

 Date:
 June 2, 2026

 EXHIBIT
INDEX

 Exhibit

 Number

 Description

 99. 1

 List of Underlying Interests of Canadian Derivatives Clearing Corporation options listed on the Montreal Exchange and offered for sale in the United States pursuant to CDCC’s Registration Statement on Form S-20 as of May 31, 2026.